ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,525.21
0.74%
US Tech 100
18,880.80
-0.11%
Dow Jones
40,113.50
0.05%
Brent Oil
65.70
-0.49%
Bitcoin
94,860.21
1.18%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. 4D Molecular Therapeutics Inc (FDMT) Quote

4D Molecular Therapeutics Inc

4D Molecular Therapeutics Inc (FDMT)

NASDAQ
3.34
0.09
(2.77%)
Closed April 25 4:00PM
Delayed by 15 minutes
3.34
0.00
( 0.00% )
Pre Market: 4:47AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
3.34
Bid
2.55
Ask
4.38
Volume
17
0.00 Day's Range 0.00
2.235 52 Week Range 28.38
Market Cap
154.65M
Previous Close
3.34
Open
-
Last Trade
1
@
3.01
Last Trade Time
04:47:58
Financial Volume
-
VWAP
-
Average Volume (3m)
827,981
Shares Outstanding
46,302,407
Dividend Yield
-
PE Ratio
-0.96
Earnings Per Share (EPS)
-3.47
Revenue
37k
Net Profit
-160.87M

About 4D Molecular Therapeutics Inc

4D Molecular Therapeutics Inc a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built portfolio of gene therapy product candidates focused in three therapeutic areas: ophthalmology (intravitreal vector), cardiology (... 4D Molecular Therapeutics Inc a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built portfolio of gene therapy product candidates focused in three therapeutic areas: ophthalmology (intravitreal vector), cardiology (intravenous vector) and pulmonology (aerosol vector). It has three product candidates in clinical trials: 4D-125 for the treatment of X-linked retinitis pigmentosa in a Phase 1/2 clinical trial, 4D-110 for the treatment of choroideremia in a Phase 1 clinical trial, and 4D-310 for the treatment of Fabry disease in a Phase 1/2 clinical trial. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration, and 4D-710 for the treatment of cystic fibrosis lung disease. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.4dmoleculartherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
4D Molecular Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker FDMT. The last closing price for 4D Molecular Therapeutics was $3.34. Over the last year, 4D Molecular Therapeutics shares have traded in a share price range of $ 2.235 to $ 28.38.

4D Molecular Therapeutics currently has 46,302,407 shares outstanding. The market capitalization of 4D Molecular Therapeutics is $154.65 million. 4D Molecular Therapeutics has a price to earnings ratio (PE ratio) of -0.96.

Ask ADVFN Intelligence (AI)

FDMT Latest News

More News

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
March 25 2025
FDMT (2.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 10 2025
FDMT (2.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 10 2025
FDMT (2.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 10 2025
FDMT (2.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 10 2025
FDMT (2.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 10 2025
FDMT (2.77%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3210.59602649013.023.792.965070863.32327141CS
4-0.19-5.382436260623.533.792.2358249702.94633985CS
12-2.085-38.43317972355.4256.912.2358279814.13147247CS
26-4.86-59.26829268298.29.17992.2358402675.49723984CS
52-20.24-85.835453774423.5828.382.23582336511.17825354CS
156-8.55-71.909167367511.8936.252.23560551115.97499692CS
260-36.66-91.654055.112.23547646717.46089549CS

FDMT - Frequently Asked Questions (FAQ)

What is the current 4D Molecular Therapeutics share price?
The current share price of 4D Molecular Therapeutics is $ 3.34
How many 4D Molecular Therapeutics shares are in issue?
4D Molecular Therapeutics has 46,302,407 shares in issue
What is the market cap of 4D Molecular Therapeutics?
The market capitalisation of 4D Molecular Therapeutics is USD 154.65M
What is the 1 year trading range for 4D Molecular Therapeutics share price?
4D Molecular Therapeutics has traded in the range of $ 2.235 to $ 28.38 during the past year
What is the PE ratio of 4D Molecular Therapeutics?
The price to earnings ratio of 4D Molecular Therapeutics is -0.96
What is the cash to sales ratio of 4D Molecular Therapeutics?
The cash to sales ratio of 4D Molecular Therapeutics is 4.18k
What is the reporting currency for 4D Molecular Therapeutics?
4D Molecular Therapeutics reports financial results in USD
What is the latest annual turnover for 4D Molecular Therapeutics?
The latest annual turnover of 4D Molecular Therapeutics is USD 37k
What is the latest annual profit for 4D Molecular Therapeutics?
The latest annual profit of 4D Molecular Therapeutics is USD -160.87M
What is the registered address of 4D Molecular Therapeutics?
The registered address for 4D Molecular Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the 4D Molecular Therapeutics website address?
The website address for 4D Molecular Therapeutics is www.4dmoleculartherapeutics.com
Which industry sector does 4D Molecular Therapeutics operate in?
4D Molecular Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LGHLWLion Group Holding Ltd
$ 0.01
(66.67%)
5
RAASMI 3Fourteen REAL Asset Allocation ETF
$ 37.53
(56.02%)
232
ASRVAmeriServ Financial Inc
$ 3.74
(54.55%)
25
DSGNDesign Therapeutics Inc
$ 5.99
(54.38%)
4
MGTXMeiraGTx Holdings PLC
$ 9.99
(49.10%)
6
TOIIWOncology Institute Inc
$ 0.0055
(-94.58%)
190
MLACMountain Lake Acquisition Corporation
$ 5.01
(-50.40%)
1
CGNTCognyte Software Ltd
$ 5.01
(-48.35%)
5
SPRBSpruce Biosciences Inc
$ 0.0818
(-36.98%)
332.45k
LCNBLCNB Corporation
$ 9.01
(-36.46%)
6
AGMHAGM Group Holdings Inc
$ 0.0685
(40.95%)
42.75M
WWWW International Inc
$ 0.4008
(1.31%)
12.13M
GNLNGreenlane Holdings Inc
$ 0.0125
(0.81%)
10.88M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 10.90
(4.31%)
10.53M
DMNDamon Inc
$ 0.0035
(0.00%)
6.91M

FDMT Discussion

View Posts
Monksdream Monksdream 4 months ago
FDMT, under $7
👍️0
Monksdream Monksdream 6 months ago
FDMT under $10
👍️0
Monksdream Monksdream 6 months ago
FDMT under $10
👍️0
Biggeoff Biggeoff 1 year ago
$70 price target by $BMO
👍️0
Monksdream Monksdream 1 year ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0

Your Recent History

NASDAQ
FDMT
4D Molecular Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads